Gregory Jackson

Director at BioLattice Ophthalmics.

Earliest Form D on file: Mar 2026

Filed Mar 30, 2026

BioLattice Ophthalmics

Synthetic cornea implant to replace donor tissue

Biotech, Philadelphia PA

Named, Director.

$575K

sold of $2.5M offered

Network

At BioLattice Ophthalmics

2 people

Linda Alunkal
Executive Officer, Director, signed as Chief Executive Officer
Amelia Zellander
Executive Officer, Director